Lower co-payments encourage preventive medicine use, study says

01/9/2008 | Forbes

U.S. employers can help increase the use of preventive drugs in patients with diabetes, high blood pressure and other chronic diseases by offering lower co-payments in their health insurance benefits, a study funded by GlaxoSmithKline PLC and Pfizer suggests. "These results bolster the idea that health insurance benefits should be designed in ways that produce the most health per dollar spent," a senior study author said.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD